CNS Treatments
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
21
NCT02641054
Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 29, 2016
Completion: Jul 31, 2017
Loading map...